Influence of up-regulation of notch ligand DLL4 on biological behaviors of human gastric cancer cells

World Journal of Gastroenterology

Volumn 19, Issue 28, 2013, Pages 4486-4494

  Li, Guo Gang ^a   Li, Lan ^a   Li, Chao ^a   Ye, Long Yun ^a   Li, Xiao Wen ^a   Liu, Da Ren ^a   Bao, Qi ^a   Zheng, Yi Xiong ^a   Xiang, Da Peng ^a   Chen, Li ^a   Chen, Jian ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Delta like ligand 4 Notch; Gastric cancer; Invasion; Matrix metalloproteinase; Migration

Indexed keywords

DELTA LIKE LIGAND 4; GELATINASE A; GELATINASE B; MATRIGEL; NOTCH RECEPTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HES 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GROWTH CURVE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR INVASION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 84880786236     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i28.4486     Document Type: Article

References (35)

1. Yeh TS, Wu CW, Hsu KW, Liao WJ, Yang MC, Li AF, Wang AM, Kuo ML, Chi CW. The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res 2009; 69: 5039-5048 [PMID: 19491270 DOI: 10.1158/0008-5472]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
3. Kim DW, Park SA, Kim CG. Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT. J Korean Med Sci 2011; 26: 875-880 [PMID: 21738339 DOI: 10.3346/ jkms.2011.26.7.875]
4. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22: 2767-2773 [PMID: 15199090]
5. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66 [PMID: 17237035]
6. Katoh M, Katoh M. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int J Mol Med 2006; 17: 681-685 [PMID: 16525728]
7. Yan M. Therapeutic promise and challenges of targeting DLL4/NOTCH1. Vasc Cell 2011; 3: 17 [PMID: 21824400 DOI: 10.1186/2045-824X-3-17]
8. Tsujinaka T, Fujitani K, Hirao M, Kurokawa Y. Current status of chemoradiotherapy for gastric cancer in Japan. Int J Clin Oncol 2008; 13: 117-120 [PMID: 18463954 DOI: 10.1007/ s10147-007-0743-1]
9. Katoh M, Katoh M. Notch signaling in gastrointestinal tract (review). Int J Oncol 2007; 30: 247-251 [PMID: 17143535]
10. Lahmar M, Catelain C, Poirault S, Dorsch M, Villeval JL, Vainchenker W, Albagli O, Lauret E. Distinct effects of the soluble versus membrane-bound forms of the notch ligand delta-4 on human CD34+CD38low cell expansion and differentiation. Stem Cells 2008; 26: 621-629 [PMID: 18055448]
11. Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, Matsui W, Eberhart CG, Maitra A, Feldmann G. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res 2009; 15: 2291-2301 [PMID: 19258443 DOI: 10.1158/1078-0432.CCR-08-2004]
12. Jubb AM, Turley H, Moeller HC, Steers G, Han C, Li JL, Leek R, Tan EY, Singh B, Mortensen NJ, Noguera-Troise I, Pezzella F, Gatter KC, Thurston G, Fox SB, Harris AL. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. Br J Cancer 2009; 101: 1749-1757 [PMID: 19844231 DOI: 10.1038/sj.bjc.6605368]
13. Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, Blades J, Li JL, Allen P, Leek R, Noguera-Troise I, Gatter KC, Thurston G, Harris AL. Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol 2010; 176: 2019-2028 [PMID: 20167860 DOI: 10.2353/ ajpath.2010.090908]
14. Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 2005; 65: 8690-8697 [PMID: 16204037]
15. Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer 2010; 116: 5676-5685 [PMID: 20737536 DOI: 10.1002/cncr.25551]
16. Dotto GP. Notch tumor suppressor function. Oncogene 2008; 27: 5115-5123 [PMID: 18758480 DOI: 10.1038/onc.2008.225]
17. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, Ball DW. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 2001; 61: 3200-3205 [PMID: 11306509]
18. Shou J, Ross S, Koeppen H, de Sauvage FJ, Gao WQ. Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res 2001; 61: 7291-7297 [PMID: 11585768]
19. Suchting S, Freitas C, le Noble F, Benedito R, Bréant C, Duarte A, Eichmann A. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 2007; 104: 3225-3230 [PMID: 17296941]
20. Oishi H, Sunamura M, Egawa S, Motoi F, Unno M, Furukawa T, Habib NA, Yagita H. Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer. Pancreas 2010; 39: 897-903 [PMID: 20182391 DOI: 10.1097/MPA.0b013e3181ce7185]
21. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G. Blockade of Dll4 inhibits tumour growth by promoting nonproductive angiogenesis. Nature 2006; 444: 1032-1037 [PMID: 17183313]
22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45 [PMID: 11328886]
23. Hawkes SP, Li H, Taniguchi GT. Zymography and reverse zymography for detecting MMPs, and TIMPs. Methods Mol Biol 2001; 151: 399-410 [PMID: 11217315]
24. Kuhnert F, Kirshner JR, Thurston G. Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vasc Cell 2011; 3: 20 [PMID: 21923938 DOI: 10.1186/2045-824X-3-20]
25. Iwasaki J, Nihira S. Anti-angiogenic therapy against gastrointestinal tract cancers. Jpn J Clin Oncol 2009; 39: 543-551 [PMID: 19531544 DOI: 10.1093/jjco/hyp062]
26. Gurney A, Hoey T. Anti-DLL4, a cancer therapeutic with multiple mechanisms of action. Vasc Cell 2011; 3: 18 [PMID: 21831306 DOI: 10.1186/2045-824X-3-18]
27. Ding XY, Ding J, Wu K, Wen W, Liu C, Yan HX, Chen C, Wang S, Tang H, Gao CK, Guo LN, Cao D, Li Z, Feng GS, Wang HY, Xu ZF. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Oncogene 2012; 31: 2899-2906 [PMID: 22002304 DOI: 10.1038/onc.2011.467]
28. Hu W, Lu C, Dong HH, Huang J, Shen DY, Stone RL, Nick AM, Shahzad MM, Mora E, Jennings NB, Lee SJ, Roh JW, Matsuo K, Nishimura M, Goodman BW, Jaffe RB, Langley RR, Deavers MT, Lopez-Berestein G, Coleman RL, Sood AK. Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer. Cancer Res 2011; 71: 6030-6039 [PMID: 21795478]
29. Fischer M, Yen WC, Kapoun AM, Wang M, O'Young G, Lewicki J, Gurney A, Hoey T. Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations. Cancer Res 2011; 71: 1520-1525 [PMID: 21193546 DOI: 10.1158/0008-5472. CAN-10-2817]
30. Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, Fitch-Bruhns M, Lazetic S, Park IK, Sato A, Satyal S, Wang X, Clarke MF, Lewicki J, Gurney A. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 2009; 5: 168-177 [PMID: 19664991 DOI: 10.1016/j.stem.2009.05.019]
31. Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J Cell Biochem 2010; 109: 726-736 [PMID: 20052673 DOI: 10.1002/jcb.22451]
32. Zheng H, Pritchard DM, Yang X, Bennett E, Liu G, Liu C, Ai W. KLF4 gene expression is inhibited by the notch signaling pathway that controls goblet cell differentiation in mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2009; 296: G490-G498 [PMID: 19109406 DOI: 10.1152/ajpgi. 90393.2008]
33. Ghaleb AM, Aggarwal G, Bialkowska AB, Nandan MO, Yang VW. Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium. Mol Cancer Res 2008; 6: 1920-1927 [PMID: 19074836 DOI: 10.1158/1541-7786.MCR-08-0224]
34. Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, Schwartz GK. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res 2009; 69: 573-582 [PMID: 19147571 DOI: 10.1158/0008-5472.CAN-08-2088]
35. Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimäki A, Haglund C. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol 2006; 59: 618-623 [PMID: 16731602]